CEO Dr. Hanadie Yousef represents Juvena on 2 panels at BIO 2025 in Boston to discuss how emerging therapeutic categories are reshaping dealmaking strategies and how the success of GLP-1/GIP therapies in promoting weight loss is driving a new era in chronic disease treatments
Dr. Hanadie Yousef participates in the World Economic Forum’s Innovator Communities Meeting and Global Technology Retreat- and shares her expert insights on 2 panels: “Breaking Barriers: Funding Frontier Tech” and “Innovation to Impact: Commercialization Insights from the Field”
Director of Translational Biology and Pharmacology, Priya Handa, PhD, and Senior Director of Discovery and Platform, Thach Mai, showcased our research at the 23rd Biopharma Drug Discovery Nexus Conference in San Francisco
CEO Dr. Hanadie Yousef shares insights on a panel, “Entrepreneurial Excellence in BioPharma: Lessons from the Frontlines,” at SynBioBeta – The Global Synthetic Biology Conference in San Jose
CEO Dr. Hanadie Yousef shares an Industry Update on JUV-161 and our plans to initiate Phase 1 studies this year at the 2025 International MDF Conference in Indianapolis
